Multifunctional MoSe 2 @MXene Heterostructure-Decorated Cellulose Fabric for Wearable Thermal Therapy.
Junwen XieYinhang ZhangJinming DaiZuoxiang XieJie XueKun DaiFei ZhangDan LiuJunye ChengFeiyu KangBaohua LiYun ZhaoLin LinQingbin ZhengPublished in: Small (Weinheim an der Bergstrasse, Germany) (2022)
A booming demand for wearable electronic devices urges the development of multifunctional smart fabrics. However, it is still facing a challenge to fabricate multifunctional smart fabrics with satisfactory mechanical property, excellent Joule heating performance, highly efficient photothermal conversion, outstanding electromagnetic shielding effectiveness, and superior anti-bacterial capability. Here, a MoSe 2 @MXene heterostructure-based multifunctional cellulose fabric is fabricated by depositing MXene nanosheets onto cellulose fabric followed by a facile hydrothermal method to grow MoSe 2 nanoflakes on MXene layers. A low-voltage Joule heating therapy platform with rapid Joule heating response (up to 230 °C in 25 s at a supplied voltage of 4 V) and stable performance under repeated bending cycles (up to 1000 cycles) is realized. Besides, the multifunctional fabric also exhibits excellent photothermal performance (up to 130 °C upon irradiation for 25 s with a light intensity of 400 mW cm -2 ), outstanding electromagnetic interference shielding effectiveness (37 dB), and excellent antibacterial performances (>90% anti-bacterial rate toward Escherichia coli, Bacillus subtilis, and Staphylococcus aureus). This work offers an efficient avenue to fabricate multifunctional wearable thermal therapy devices for mobile healthcare and personal thermal management.
Keyphrases
- drug delivery
- cancer therapy
- highly efficient
- metal organic framework
- escherichia coli
- healthcare
- staphylococcus aureus
- randomized controlled trial
- bacillus subtilis
- systematic review
- heart rate
- photodynamic therapy
- reduced graphene oxide
- quantum dots
- stem cells
- gold nanoparticles
- radiation therapy
- high intensity
- aqueous solution
- multidrug resistant
- cystic fibrosis
- risk assessment
- smoking cessation
- cell therapy